Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

Shalamar suffered from chronic insomnia. She couldn’t fall asleep after her late-night shifts as a server at a New York City bar. To address the insomnia, she sought advice from a psychiatrist who prescribed pills and told her to take them both at night and in the morning. She thought it was odd that she would need to take a pill to help her sleep during the day, but her doctor said that is how the medicine worked. She followed the doctor’s recommendations, though. “It did help me to sleep. I slept like a rock,” she says.  What her doctor…

Read More
FDA

If you watch television, you’ve likely seen the commercials for the JAK (Janus kinase) inhibitors Xeljanz and Rinvoq that make bold claims. Those ads depict men and women ziplining, moving large amounts of heavy soil, hauling furniture and riding ATVs. “The [misleading] message is that you don’t have to be limited in any way,” explains Terry Graedon, PhD, a medical anthropologist and co-host of The People’s Pharmacy. “I would say that the likelihood [is pretty slim] that this is a realistic goal for most people, much less women with rheumatoid arthritis,  especially if they are people whose condition has not…

Read More

The incidence of depression and anxiety has surged among adults in the United States over the course of the COVID-19 pandemic, according to the Centers for Disease Control and Prevention (CDC). The CDC survey suggested that from 2019 to 2020, symptoms of anxiety disorders and depression have tripled and quadrupled, respectively. As you might expect, prescriptions for antidepressant and antianxiety drugs also have spiked, according to the telehealth platform iPrescribe. While many patients with severe or chronic depression or anxiety may need to continue using these medications long term, you may think that, given the return of opportunities for working…

Read More